| |
Latest 10 SEC filings (by transaction date) for IQV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Stock Appreciation Right | M - Exercise or conversion exempt under rule 16b-3 | -42,847 | $65.16 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | D - Disposition to issuer under Rule 16b-3(e) | -11,169 | $249.97 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | S - Open market or private sale | -15,417 | $251.03 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | S - Open market or private sale | -16,261 | $250.05 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 42,847 | $65.16 |
Mar 4/24 | Feb 29/24 | Staub W Richard | Direct Ownership | Common Stock | S - Open market or private sale | -2,068 | $249.08 |
Mar 4/24 | Feb 29/24 | Staub W Richard | Direct Ownership | Common Stock | S - Open market or private sale | -3,062 | $248.33 |
Mar 4/24 | Feb 29/24 | Staub W Richard | Direct Ownership | Common Stock | S - Open market or private sale | -8,970 | $247.33 |
Mar 1/24 | Feb 28/24 | Knightly Kevin C | Direct Ownership | Stock Appreciation Right | M - Exercise or conversion exempt under rule 16b-3 | -7,131 | $95.23 |
Mar 1/24 | Feb 28/24 | Knightly Kevin C | Direct Ownership | Stock Appreciation Right | M - Exercise or conversion exempt under rule 16b-3 | -6,075 | $78.21 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for IQV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Stock Appreciation Right | M - Exercise or conversion exempt under rule 16b-3 | -42,847 | $65.16 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | D - Disposition to issuer under Rule 16b-3(e) | -11,169 | $249.97 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | S - Open market or private sale | -15,417 | $251.03 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | S - Open market or private sale | -16,261 | $250.05 |
Mar 4/24 | Mar 1/24 | Bousbib Ari | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 42,847 | $65.16 |
Mar 4/24 | Feb 29/24 | Staub W Richard | Direct Ownership | Common Stock | S - Open market or private sale | -2,068 | $249.08 |
Mar 4/24 | Feb 29/24 | Staub W Richard | Direct Ownership | Common Stock | S - Open market or private sale | -3,062 | $248.33 |
Mar 4/24 | Feb 29/24 | Staub W Richard | Direct Ownership | Common Stock | S - Open market or private sale | -8,970 | $247.33 |
Mar 1/24 | Feb 28/24 | Knightly Kevin C | Direct Ownership | Stock Appreciation Right | M - Exercise or conversion exempt under rule 16b-3 | -7,131 | $95.23 |
Mar 1/24 | Feb 28/24 | Knightly Kevin C | Direct Ownership | Stock Appreciation Right | M - Exercise or conversion exempt under rule 16b-3 | -6,075 | $78.21 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Medpace Holdings (OQ:MEDP) |
Disc Medicine (OQ:IRON) |
United Therapeutics (OQ:UTHR) |